<H1>Chapter DOI: 10.1208/aapsj070106<br/>Cited-By Count: 12</H1><table border="1" width="30%"><tr><td>Total References</td><td>13</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>13</td></tr><tr><td>BibStructured Count</td><td width="10%">4</td></tr><tr><td>BibUnstructured Count</td><td width="10%">9</td></tr><tr><td>DOI already available in SpringerLink</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>2</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>2</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Food and Drug Administration, Center for Drug Evaluation and Research</span>. <span style='background:#FFD9B3'>Guidance for Industry Levothyroxine Sodium Tablets&#8212;In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing</span>. <span style='background:#C0FFC0'>Rockville, MD</span>: <span style='background:#FFFF49'>February</span> <span style='background:#66FF66'>2001</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#DDDDDD'>Citizen's</span> <span style='background:#BCBCBC'>Petition</span></span></aug>. <span style='background:#FFFF49'>Jones Pharma, Inc</span>. March 28, <span style='background:#66FF66'>2003</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#DDDDDD'>Citizen's</span> <span style='background:#BCBCBC'>Petition</span></span></aug>. <span style='background:#FFD9B3'>Abbott Laboratories</span>. August 25, <span style='background:#66FF66'>2003</span>.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1002/div.5871>10.1002/div.5871</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Blakesley V, Awni W, Locke C, Ludden T, Granneman GR, Braverman LE. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?<Emphasis Type="Italic">Thyroid</Emphasis>. 2004;14:191&#8211;200.</td><td><a href=http://dx.doi.org/10.1089/105072504773297867>10.1089/105072504773297867</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibUnstructured</td><td>Food and Drug Administration. FDA Advisory Committee for Pharmaceutical Science. <i>Briefing Document From Abbott Laboratories</i>. Rockville, MD; May 12&#8211;13, 2003. Available at: <span style='background:#FF3300'>http://www.fda.gov/ohrms/dockets/ac/03/briefing/3926B1_02_A-Abbott%20.htm</span>. Accessed March 23, 2005.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibBook</td><td>Mylan Laboratories, Inc.<Emphasis Type="Italic">Levothyroxine Sodium Tablets</Emphasis>. Canonsburg, PA: Mylan Laboratories, Inc; 2000:76&#8211;187.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibUnstructured</td><td>Food and Drug Administration. FDA Advisory Committee for Pharmaceutical Science. Record of Proceedings. March 13, 2003. Available at: <span style='background:#FF3300'>http://www.fda.gov/ohrms/dockets/ac/cder03.html#</span> <span style='background:#FFFF0F'>Pharmaceutical Science. Accessed March 23, 2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#DDDDDD'>Citizen's</span> <span style='background:#BCBCBC'>Petition</span></span></aug>. <span style='background:#FFD9B3'>Abbott Laboratories</span>. August 25, <span style='background:#66FF66'>2003</span>.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1002/div.5871>10.1002/div.5871</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR9</td><td>BibUnstructured</td><td>Food and Drug Administration. FDA Response to Abbott Petition, Citizen's Petition #2003P-0126/CP1, Document PDN 1. June 29, 2004.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment.<Emphasis Type="Italic">J Clin Endocrinol</Emphasis>. 1988;28:325&#8211;333.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2265.1988.tb01219.x>10.1111/j.1365-2265.1988.tb01219.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibUnstructured</td><td>Food and Drug Administration. Code of Federal Regulations. Title 21, Volume 5: CFR 320.33. Available at: <span style='background:#FF3300'>http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfefr/CFRSearch.cfm?fr=320.24</span>. Accessed: March 23, 2005.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibBook</td><td>Bolton S, Bon C.<Emphasis Type="Italic">Pharmaceutical Statistics, Practical and Clinical Applications</Emphasis>. 4th ed. New York, NY: Marcel Dekker; 2003.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Health Canada</span>. <span style='background:#FFD9B3'>Expert Advisory Committee on Bioavailability</span>. Record of Proceedings. April 16, <span style='background:#66FF66'>2003</span>. Available at <span style='background:#FF3300'>http://www.hc-sc.gc.ca/hpfbdgpsa/tpd-dpt/2003-04-16_e.html</span>. <span style='background:#FFFF0F'>Accessed March 23, 2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>